Monica Gandhi, MD, MPH, talks meningitis vaccination & prevention strategies, high-risk populations, vaccination coverage, & ...

Nirsevimab immunization effectively decreases the risk for RSV-related LRTI hospitalizations in an infant's first year.

Influenza mortality increased among US children over 25 years despite declines in other vaccine-preventable deaths.

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

Long-term fumarate therapy for multiple sclerosis, compared with anti-CD20 therapy, is linked to a reduced risk for infection.

Dr Marissa Robinson discusses structural barriers to HIV PrEP access and strategies to enhance health equity in care delivery ...

Ceftazidime-avibactam therapy yields a high clinical response rate in patients with MDR Gram-negative pneumonia in routine practice.

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...

Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.